Vicore Pharma Holding AB (publ)
SSE:VICO.ST
14.38 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||
Net Income
| -310.942 | -290.725 | -294.818 | -149.538 | -94.014 | -41.586 | -12.793 | -6.649 | -4.543 | -5.34 | -1.603 | -0.003 |
Depreciation & Amortization
| 65.976 | 3.612 | 3.598 | 3.537 | 1.338 | 0.007 | 0.007 | 0.006 | 0.006 | 0.036 | 0.04 | 0 |
Deferred Income Tax
| -0.007 | -0.005 | 0.002 | -0.008 | -0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 6.9 | 4.872 | -1.563 | 8.2 | 4.588 | 1.995 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -10.646 | -20.94 | 27.073 | 22.681 | 3.558 | 8.037 | 0.276 | -0.605 | 0.838 | 2.159 | 0.702 | -0 |
Accounts Receivables
| -2.694 | -1.598 | -0.34 | -3.867 | 0.234 | -1.275 | -0.174 | 0.638 | -0.785 | 0.268 | 0.351 | -0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| -7.952 | -19.342 | 27.413 | 26.548 | 3.324 | 9.312 | 0.45 | -0.128 | 1.75 | 0 | 0 | 0 |
Other Working Capital
| -6.362 | 0 | 0 | 0 | 0 | 0 | 0 | -1.115 | -0.127 | 2.018 | 0.351 | 0 |
Other Non Cash Items
| 6.029 | 8.134 | -1.024 | 3.385 | 2.119 | 0.506 | 4.805 | -0.003 | 0.017 | 0.32 | -0.932 | 0.001 |
Operating Cash Flow
| -249.583 | -299.919 | -265.171 | -119.935 | -86.999 | -33.036 | -7.705 | -7.251 | -3.682 | -2.825 | -1.793 | -0.002 |
Investing Activities: | ||||||||||||
Investments In Property Plant And Equipment
| -199.039 | -3 | 0 | -3 | -0.147 | -2 | -20.233 | -13.477 | -5.657 | -9.49 | 0 | -0 |
Acquisitions Net
| 0 | 0 | 0 | 3 | 0 | 20.258 | 0 | 0 | 0 | 7.1 | 0 | 0 |
Purchases Of Investments
| -199.039 | 0 | -77 | -70 | -77 | -3.228 | -2.545 | -0.5 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 54.584 | 77 | 70 | 77 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 199.039 | 0.074 | -0.007 | -3 | -0.077 | -2 | -2.545 | -0.5 | -5.657 | -2.39 | -2.87 | -0.004 |
Investing Cash Flow
| -144.455 | 74 | -7 | 4 | -77.147 | 15.03 | -22.778 | -13.977 | -5.657 | -2.39 | -2.87 | -0.005 |
Financing Activities: | ||||||||||||
Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.1 | 0 | 0 |
Common Stock Issued
| 470.918 | 187.292 | 336 | 187.55 | 134.829 | 232.42 | 50.236 | 0.319 | 32.804 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| -0.063 | 187.04 | -17.817 | -10.583 | -7.785 | -13.745 | 50.236 | 0.319 | 32.804 | 0 | 14.979 | 0 |
Financing Cash Flow
| 470.855 | 187.04 | 318.183 | 176.967 | 127.044 | 218.675 | 50.236 | 0.319 | 32.804 | -7.1 | 14.979 | 0 |
Other Information: | ||||||||||||
Effect Of Forex Changes On Cash
| 0 | 1.483 | -0.431 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| 76.817 | -37.396 | 45.581 | 61.032 | -37.102 | 200.669 | 19.753 | -20.909 | 23.465 | -12.315 | 10.316 | -0.006 |
Cash At End Of Period
| 333.62 | 256.803 | 294.199 | 248.618 | 187.586 | 224.688 | 24.019 | 4.266 | 25.175 | 1.71 | 14.025 | 0.004 |